IM Cannabis Corp. Announces Corporate Update Following Director Resignation

IM Cannabis Corp. Corporate Update

Introduction
IM Cannabis Corp. (Nasdaq: IMCC), a prominent player in the medical cannabis industry with operations in Israel and Germany, has made headlines recently with a notable corporate update. This announcement comes on July 27, 2026, shedding light on significant internal changes as well as the company's ongoing strategic directions.

Director Resignation
One of the primary highlights of the update is the resignation of Mr. Alon Dayan from the company's board of directors. Mr. Dayan stepped down for personal reasons, leaving behind a legacy of valuable contributions during his tenure. The management and board extended their heartfelt gratitude for his service, recognizing his impact on the company's trajectory. This transition opens up new avenues for IM Cannabis Corp. as it continues to adapt and grow in a competitive market.

IM Cannabis' Operations
The corporation has positioned itself at the forefront of the medical cannabis sector. Operating primarily in Israel and Germany, the company is dedicated to serving medical cannabis patients through a robust platform. This includes importing, distributing, and retailing cannabis products, all under stringent quality controls and regulations.

In Israel, IM Cannabis operates through a network of subsidiaries, focusing on providing safe and effective delivery of cannabis products. Their retail pharmacies and online platforms enhance accessibility for patients, ensuring that they receive high-quality products tailored to their medical needs. In Germany, the company operates through Adjupharm GmbH, where it aims to streamline the distribution of medical cannabis to pharmacies, improving patient access throughout the country.

Future Expansion and Innovations
IM Cannabis Corp. is also actively exploring opportunities to expand its presence into technology-driven sectors related to the cannabis industry. By leveraging years of proprietary data and insights gained from patient interactions, IM Cannabis is uniquely positioned to enhance its operational efficiency and customer engagement strategies. These attempts reflect the company's commitment to innovation within the healthcare and cannabis landscape.

Forward-Looking Statements
While the corporation's focus remains on maintaining and expanding its operational footprint, it cautions stakeholders regarding the uncertainties inherent in the highly regulated cannabis industry. Future growth will depend on obtaining necessary licenses, adapting to changing market dynamics, and keeping pace with regulatory developments. As part of its corporate governance, IM Cannabis is dedicated to responsible management practices while navigating these challenges.

Conclusion
In summary, the recent corporate update from IM Cannabis Corp. highlights a shift in its leadership and reinforces its commitment to patient care and market expansion in the medical cannabis arena. With a clear strategic vision, the company aims to enhance its operations and meet the growing demand for medicinal cannabis solutions, positioning itself as a leader in this vital industry.